What is NDC 68001-505?

68001-505 is the product NDC for Polyethylene Glycol, Polyethylene glycol 3350 17 g/17g powder, for suspension, listed with the FDA by BluePoint Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.

BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Polyethylene Glycol?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Polyethylene Glycol NDC 68001-505 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68001-505Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68001-0505Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68001-505-55	6800105055568001050555	238 g in 1 BOTTLE (68001-505-55)Marketed from Jun 18, 2021
68001-505-69	6800105056968001050569	510 g in 1 BOTTLE (68001-505-69)Marketed from Jun 18, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Polyethylene Glycol
Generic name (nonproprietary): polyethylene glycol
Active ingredients: Polyethylene glycol 3350 — 17 g/17g
Dosage form: Powder, For suspension
Route: Oral
Labeler: BluePoint LaboratoriesNDC labeler code 68001
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091077
Marketing start: Jun 18, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 68001-505_cc6e2865-14e2-1ac7-e053-2a95a90acbc0SPL ID cc6e2865-14e2-1ac7-e053-2a95a90acbc0SPL set ID c4cae70c-68da-0bbc-e053-2a95a90a395aUNII G2M7P15E5P
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468001050555 followed by a unit qualifier and the quantity

Package 68001-0505-55. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 20, 2021.

Indications (excerpt from the label)

USE Relieves occasional constipation (irregularity) Generally produces a bowel movement in 1 to 3 days

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68001-505

What is NDC 68001-505?: 68001-505 is the product NDC for Polyethylene Glycol, Polyethylene glycol 3350 17 g/17g powder, for suspension, listed with the FDA by BluePoint Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Polyethylene Glycol.
What is the active ingredient?: Polyethylene glycol 3350.
Who is the labeler?: BluePoint Laboratories, NDC labeler code 68001. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Polyethylene Glycol?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 091077

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091077
Product	Strength	Form · route	Labeler	Product NDC
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	Atlantic Biologicals Corp.	17856-0310
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	ATLANTIC BIOLOGICALS CORP.	17856-0312
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	Lupin Pharmaceuticals,Inc.	43386-312
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	A-S Medication Solutions	50090-5310
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	Proficient Rx LP	63187-368
Gavilaxpolyethylene glycol 3350	Polyethylene glycol 3350 17 g/17g	Powder, For solutionOral	Preferred Pharmaceuticals, Inc.	68788-7508